Investor Alert - Cybin: Changing the Mental Healthcare Experience
Cybin is a biotech company in the psychedelic therapeutic sector. Their team is focused on the development of mental healthcare treatment with a singl …
On a mission to revolutionize mental healthcare
Cybin is a biotech company in the psychedelic therapeutic sector. Their team is focused on the development of mental healthcare treatment with a single-minded goal to dramatically improve patient outcomes versus currently available pharmacotherapies.
Their work includes the development of new drug molecules, with a focus on optimizing treatment outcomes through innovative drug delivery systems, concurrent therapy regimens, and technology-driven patient analytics.
For more information on Cybin Inc. (NEO: CYBN, NYSE AMERICAN: CYBN) please click the request investor info button.
Latest Articles
.png)
Hot Companies
You might also like
Caldwell-Lazard CorePlus Infrastructure ETF: Why Is Infrastructure Becoming a Long-Term Investment Theme?
The Caldwell-Lazard CorePlus Infrastructure ETF provides investors with diversified exposure to global infrastructure through the first ETF listed on the Canadian Securities Exchange.
CEO Clip- Chilean Cobalt: Why Copper and Cobalt Are Critical to Electrification and Advanced Technology
The global shift towards greater electrification and advanced technology is increasing demand for the critical minerals required to build and power the technologies of the future.
